Promoter collection, Human SOD1 promoter
Alternative name | U2950-3 |
---|---|
Clone info. | PCR amplified human SOD1 promoter sequence was inserted into a firefly luciferase vector. Cloned fragment: 31658211 to 31659681(NC_000021.9); relatively -1411 to +60, where +1 corresponds to 1 nt of NM_000454.4. |
Comment | PCR cloning, forward primer: gaaatctgccgaacttcctg; reverse primer: ccgtctccgcgactacttta. Entire sequence of promoter region has not been confirmed. |
Vector backbone | pGL4.10 [Luc2] (Plasmid) |
Selectable markers | Amp^r |
Gene/insert name | Human superoxide dismutase 1, soluble genomic DNA |
Depositor|Developer | DNA Bank, | |
Remarks, protocol and/or map (pdf) | RDB07686.pdf |
---|
Please check terms and conditions set forth by the depositor, which are specified in the RIKEN BRC Catalog and/or Web Catalog.
Ordering forms | Order form [Credit Card Payment] [Bank Transfer Payment] [Example of order form ] MTA, for use for not-for-profit academic purpose [Word] [Example of MTA ] Please visit Information of Request for Distribution.[link] |
---|---|
Terms and conditions for distribution | In publishing the research results to be obtained by use of the BIOLOGICAL RESOURCE, an acknowledgment to the DEPOSITOR is requested. Additional terms and conditions: The use of the BIOLOGICAL RESOURCE is restricted to the academic researches conducted by non-profit organization. By using this material, the RECIPIENT agrees to be bound by the conditions of the limited use statement of the Promega Corporation. |
必要書類 | 提供依頼書 [依頼書の記入例 ] 提供同意書 (MTA, 非営利学術目的用)[Word] [MTAの記入例 ] 手続きの概要は、「提供申込みについて[link]」をご覧ください。 |
---|---|
MTAに書く使用条件 | 謝辞の表明を必要とする。 MTAに書く付加的使用条件: 本件リソースの使用は学術機関での学術研究に限る。本件リソースの使用にあたって、利用者はプロメガ社の限定使用条件に従う必要がある。 |
Catalog # | Resource name | Shipping form | Fee (non-profit org.) |
---|---|---|---|
RDB07686 | pGL4-phSOD1 | DNA solution |
Materials & Methods section:
The pGL4-phSOD1 was provided by the RIKEN BRC through the National BioResource Project of the MEXT, Japan (cat. RDB07686). |
Reference section:
Further references such as user reports and related articles (go to bottom)
RIKEN BRC has sequenced portions of this material for quality test.
Please review the QC test results indicated by icon as well as clone information before placing your order.
Test sheet | RDB07686_A4Lm.pdf |
---|
Nucleotide sequence of a portion of this resource (if available).
Primer: pGL4-4174F Sequence file: RDB07686_A4Lma.seq |
---|
>07686_07686_A4Lm_pGL4-4174F_G07_19.ab1 1 GGTGGGTCAG ACATTTCTCT GGCCTACTGG CCGGTACCTG AGCTCGCTAG CCTCGAGGAT 61 GAAATCTGCC GAACTTCCTG GAACCCAAAG AAACTTTAGC CTTGGGCAAA GGCCCTTTGG 121 CCAGCATTTG CACTGTTTAT GCAACCGTTT AGAATATACG AATTATCTGG AGACTACTAC 181 CAAATACAAC AGGCAAAACT GCAAATATGT ATACTTCCTA GAGGATGATA AAAAAATGTG 241 AATTGTATTT CTCTGATAGA GGATGCATTA GAGTCTGAGG GTCTAAATAG CGTAAATAAT 301 AAATAAGTAA ATAAATCGAT AGTAGTGTAC TCCAAACGAG GCTGGAATAG CTTCTATTGT 361 TGTTTCACAC TGGACTTCAA TTAAGTCTCA GTATTTTGCC ATACTCAATA TTAAGTACTA 421 GGCTGGACGT GGTGGCTCAT GTCTGTAATC CCAGCACTTT GGGAGGCCGA GGTGGGTAGA 481 TGGCTGGCTT GAGCTCAGGA GTTTGAAACC AGCCTGGGCA ACATGGTAAA ACCCCATCTG 541 TACCCAAAAT ACAAAAATCA GCCAGGTGTG GTGGCACATG CCTGTGGTCC CAGGTACTTG 601 GGAGGCTGAG GCAGGAGGAT GGCTTGAACC CAGGAGGTGG AGGCTGCAGT GAGCTATGAT 661 GGCGCCACTG CACTCCAGCC TGGGTGACAG AGCGAGACCC TGTCTCAAAA ATCAAACAAA 721 CAACCCCCTC GCCCCGGACA AAAGTAGTTT GCACTATTTT CTCATTTCAC AATATGTTTT 781 TGAAATATTT CCCTTGAAAG GTAAGTCATA TTTATCATTC CTGTTGTATG GAGGCATCAT 841 AAATTATTTC ACCATTCTAC CCTCCTTGAG TGTTGTGGCC TTTAGCCAGA CAAAACGCAG 901 TGATGCCTAG AGCCAACTAG TGCCGTTTGT ATCTGTAGGT GTGCCTGCCA ACAGAAAATA 961 TAAAGATACG ATCTGCACAA TTAGAAATCT ATACTAGACT AGAAATGCAG GGAAGAAAGT 1021 TAGTCCGGGA TGAGGTGTAA CGACTTTCTA TACCCTCGAA ACTAAAACCA GACCAAATTG 1081 AAACTACAAG GCACTCACTG GGCGTCCAAT GTCTGATACA TGAAGCCTGG CAACTCAGGC 1141 TTAC // |
Primer: pGL4-136R Sequence file: RDB07686_A4Lmb.seq |
>07686_07686_A4Lm_pGL4-136R_H07_22.ab1 1 GCTTTCTAGT TTATGGCATC TTCATGGTGG CTTTACCAAC AGTACCGGAT TGCCAAGCTT 61 GGCCGCCGAG GCCAGATCTT GATCCGTCTC CGCGACTACT TTATAGGCCA GACCTCCGCG 121 CCTCGCCCAC TCTGGCCCCA AACCAATCGC CTCGCACGCG CTCAGCCCGC CCCCTGCGGC 181 AGCCTCGGGT CGCGAGTGGC CGGGAATGAC TGGGGGCGGG GCCAAGGGGC CGCGTGCGCC 241 GGAGACTCCC CCCGCCCCGC AGCCGGGAAA CGTCCAGAAC CCCGAAATGT GGAGAAAACA 301 ACCTTCTTTT CACGGGGGCG TGGCCCGCCG GTTGCAGTAC GCGAAATTGG CAAAATGATG 361 TAAACAGGGT ACGCTTTGAA AATCTGAAGT CACTTTGTCT AGAAATGTCA TTAGTTATGA 421 CTGAGTTTGG CCACAGCGTC TCATTTGTTA CTCAGCAATT GGGACGCCCC AAGATGGATG 481 CTTTTGTAGT TTTCATTTTT TTGTCTTGTT TTTTAGTTTT CTGAGGGTAT AGAAAGTCGC 541 TACACCTCAA TCCCGGGACT TACCTTTTCT TCCCCTGCAA TTTTCTTAGT CCTTAGTATA 601 GATTTTCTTA TTTGGTTGGC AGAATTCGGT ATTCTTTTTA TATTTTTCCT GTTTGGCAAG 661 GCCACAACCC TACAGATAAC CAAACGGCAA CTAGTTGGCT TCTAGGCATC ACCTGCGTTT 721 TTGTCTGGCC TAAAGGCCAC AACACTCAAG GAGGGTAGAA TGGTGAAATA ATTTATGATG 781 CCTCCATACA ACAGGAATGA TAAATATGAC TTACCTTTCA AGGGAAATAT TTCAAAAACA 841 TATTGTGAAA TGAGAAAATA GTGCAAACTA CTTTTGTCCG GGGCGAGGGG GTTGTTTGTT 901 TGATTTTTGA GACAGGGTCT CGCTCTGTCA CCCAGGCTGG AGTGCAGTGG CGCCATCATA 961 GCTCACTGCA GCCTCCACCT CCTGGGTTCA AGCCATCCTC CTGCCTCAGC CTCCCAAGTA 1021 CCTGGGACCA CAGGCATGTG CCACCACACC TGGCTGATTT TGTATTTTGG GTACAGATGG 1081 GGGTTTTACC ATGATGACCA GCTGCTTCAA CTCTTGAGCT CAAGGTCAGC ATCTACCAAC 1141 TCGGACTTCC GAAATGCTGG TATACGTACA TTGAAGCGAT CTTAAACGT // |
Please visit Sequencing and PCR primers for primer information.
Original, user report and related articles
Featured content